SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-014784
Filing Date
2023-05-01
Accepted
2023-04-28 19:30:10
Documents
17
Period of Report
2023-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 49955
2 ex1-1.htm EX-1.1 503070
3 ex5-1.htm EX-5.1 23929
4 ex99-1.htm EX-99.1 13372
5 ex99-2.htm EX-99.2 12194
6 ex5-1_001.jpg GRAPHIC 5273
  Complete submission text file 0001493152-23-014784.txt   911479

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE hils-20230427.xsd EX-101.SCH 3242
8 XBRL LABEL FILE hils-20230427_lab.xml EX-101.LAB 34916
9 XBRL PRESENTATION FILE hils-20230427_pre.xml EX-101.PRE 22799
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3877
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Hillstream BioPharma Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 23869372
SIC: 2834 Pharmaceutical Preparations